Peripheral T-cell lymphomas (PTCL) are heterogeneous and highly aggressive hematologic
malignancies with dismal outcomes, highlighting the need for novel targeted therapies …

Peripheral T cell lymphoma (PTCL) is a heterogeneous group of non-Hodgkin's lymphomas
varying in clinical, phenotypic, and genetic features. The molecular pathogenesis and the …

Background: Emerging evidence suggests the prognostic impact of the tumor
microenvironment (TME) in peripheral T-cell lymphomas (PTCLs). Aims: To better …

Background: The contribution of the tumor microenvironment (TME) to Peripheral T-Cell
Lymphomas (PTCL) pathogenesis has been increasingly recognized. Despite recent …

Peripheral T-cell lymphomas (PTCLs) encompass a diverse group of aggressive non-
Hodgkin's lymphomas originating from mature T lymphocytes. Despite their relatively low …

Peripheral T-cell lymphoma (PTCL) is heterogenous group of mature T-cell neoplasms
characterized by distinctive transcriptional and genetic lesions. Herein, we investigated …

T-cell lymphomas (TCLs) comprise a heterogeneous group of malignancies. Current
therapeutic options remain limited, partly given the scarcity of representative preclinical …

Peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS) is a diagnosis of
exclusion, being the most common entity in mature T-cell neoplasms, and its molecular …

Peripheral T-cell lymphomas (PTCL) remain a diagnostic challenge, and the most common
subtype remains “unspecified”. However, improved understanding of the transcriptional and …

BACKGROUND: Angioimmunoblastic T cell lymphoma (AITL) has a unique histological
profile comprised of a relatively small number of malignant CD4+ T-cells of TFH phenotype …